MedMerits Home

News

Stimulating brain cells stops binge drinking, animal study finds
Jan 06, 2014
Researchers at the University at Buffalo have found a way to change alcohol drinking behavior in rodents, using the emerging technique of optogenetics, which uses light to stimulate neurons. Their work could lead to powerful new ways to treat alcoholism, other addictions, and neurologic and mental illnesses; it also helps explain the underlying neurochemical basis of drug addiction.
Chewing gum is often the culprit for migraine headaches in teens
Dec 19, 2013
Dr Nathan Watemberg of Tel Aviv University-affiliated Meir Medical Center has found that gum-chewing teenagers, and younger children as well, are giving themselves headaches by chewing gum. His findings, published in Pediatric Neurology, could help treat countless cases of migraine and tension headaches in adolescents without the need for additional testing or medication.
FDA approves second brain imaging drug to help evaluate patients for Alzheimer disease, dementia
Oct 28, 2013
The US Food and Drug Administration has approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer disease and dementia.
Breakthrough offers first direct measurement of spinal cord myelin in multiple sclerosis
Sep 23, 2013
Case Western Reserve University School of Medicine scientists have developed a novel molecular probe detectable by PET imaging. The new molecular marker, MeDAS, offers the first noninvasive visualization of myelin integrity of the entire spinal cord at the same time, as published today in an article in the Annals of Neurology.
Largest study of epilepsy patients ever conducted reveals new and surprising genetic risk factors
Aug 12, 2013
Neurologists and epilepsy researchers have identified 329 random genetic mutations associated with 2 of the most severe forms of epilepsy, according to a paper published today in Nature. This study sheds light on why some with an elevated risk for epilepsy never get the disease and why certain medications work better for some patients than others.
Newly identified bone marrow stem cells reveal markers for amyotrophic lateral sclerosis
Jul 10, 2013
Using samples of stem cells derived from the bone marrow of non-genetic amyotrophic lateral sclerosis patients, a team of researchers have uncovered 4 different biomarkers that characterize the non-genetic form of the disease.